Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma 10Lymphoma, Large B-Cell, Diffuse 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Follicular 5Burkitt Lymphoma 4Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Sarcoma 2Retinoblastoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Anaplastic 2Immunoblastic Lymphadenopathy 2Dendritic Cell Sarcoma, Interdigitating 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Vomiting 1Sezary Syndrome 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nausea 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Primary Effusion 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

pevonedistat 1Vincristine 1Rituximab 1Prednisone 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Acromesomelic dysplasia, Maroteaux type × Vincristine × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡